Lista de obras -

5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity

artículo científico publicado en 2016

5-Hydroxymethylcytosine: A new player in brain disorders?

artículo científico publicado en 2015

6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death

artículo científico publicado en 2011

A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport ⬇️

artículo científico publicado el 12 de junio de 2012

A locus affecting obesity in human chromosome region 10p12.

artículo científico publicado en 2001

Cervical HSV-2 infection causes cervical remodeling and increases risk for ascending infection and preterm birth.

artículo científico publicado en 2017

Developmental Dieldrin Exposure Alters DNA Methylation at Genes Related to Dopaminergic Neuron Development and Parkinson's Disease in Mouse Midbrain

artículo científico publicado en 2019

Fungal-derived semiochemical 1-octen-3-ol disrupts dopamine packaging and causes neurodegeneration

artículo científico publicado en 2013

Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.

artículo científico publicado en 2016

In Vitro and In Vivo Characterization of the Alkaloid Nuciferine

artículo científico publicado en 2016

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo

artículo científico publicado en 2014

MPP+-induces PUMA- and p53-dependent, but ATF3-independent cell death ⬇️

artículo científico publicado el 14 de marzo de 2013

Oxidative signaling in experimental autoimmune encephalomyelitis.

artículo científico publicado en 2010

Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease.

artículo científico publicado en 2017

The vesicular monoamine transporter 2: an underexplored pharmacological target

artículo científico publicado en 2014

Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals.

artículo científico publicado en 2016

Vesicular integrity in Parkinson's disease

artículo científico publicado en 2013

Lista de obras de

5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity

5-Hydroxymethylcytosine: A new player in brain disorders?

6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death

A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport ⬇️

A locus affecting obesity in human chromosome region 10p12.

Cervical HSV-2 infection causes cervical remodeling and increases risk for ascending infection and preterm birth.

Developmental Dieldrin Exposure Alters DNA Methylation at Genes Related to Dopaminergic Neuron Development and Parkinson's Disease in Mouse Midbrain

Fungal-derived semiochemical 1-octen-3-ol disrupts dopamine packaging and causes neurodegeneration

Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.

In Vitro and In Vivo Characterization of the Alkaloid Nuciferine

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo

MPP+-induces PUMA- and p53-dependent, but ATF3-independent cell death ⬇️

Oxidative signaling in experimental autoimmune encephalomyelitis.

Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease.

The vesicular monoamine transporter 2: an underexplored pharmacological target

Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals.

Vesicular integrity in Parkinson's disease